MedTrace Logo

Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures

NCT07530497 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-08-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.

Conditions

  • Fracture; Pelvic
  • Insufficiency Fractures
  • Fragility Fracture
  • Sacroiliac; Fusion
  • Sacroiliac Joint Disruption
  • Sacroiliac Joint Dysfunction

Interventions

DEVICE

iFuse TORQ TNT Implant System

FDA-clear implant used for fracture fixation of the pelvis, including acute, non-acute, and non-traumatic fractures and sacroiliac joint fusion for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis.

Sponsors & Collaborators

  • SI-BONE, Inc.

    lead INDUSTRY

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2028-02-29
Completion
2028-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07530497 on ClinicalTrials.gov